M Lemma (Milan, Italy) puts forward the argument in favour of off-pump coronary bypass surgery.
M Lemma (Milan, Italy) puts forward the argument in favour of off-pump coronary bypass surgery.
A Baker (Glasgow, UK) explains the potential use of gene therapy in improving the outcomes of coronary bypass grafts.
N Curzen (Southampton, UK) explains the importance of physiological ischaemia and FFR in deciding optimal management for coronary disease.
C Royse (Melbourne, Australia) explains why he believes that the key to reducing risk of stroke is aortic assessment.
E Orion (Tel Aviv, Israel), the co-inventor of the device, looks at the evidence for using an external support to improve vein graft patency.
G. Angelini (London, UK) considers the evidence for single versus multiple arterial grafts in coronary bypass surgery, looking to explain why saphenous vein remains the second conduit of choice in the majority of cases worldwide.
P Quax (Leiden, Netherlands) describes the basic science behind vein graft remodelling, considering what factors trigger the inflammatory response.
D Taggart (Oxford, UK) looks at the evidence for external stenting of vein grafts to optimise long-term outcomes.
A. Newby (Bristol, UK) discusses the incidence and causes of vein graft failure. He considers options to improve outcomes, in particular the use of periadventitial human stem cells.
D Taggart (Oxford, UK) summarises the debate on the evidence for completeness of myocardial revascularisation.
C Hamm (Bad Nauheim, Germany) reviews the evidence for the benefits of complete revascularisation in percutaneous coronary intervention.
P Kolh (Leige, Belgium) considers the long-term results of arterial revascularisation, the SYNTAX trial and the 2010 European Revascularisation Guidelines.
D Taggart of John Radcliffe Hospital, Oxford looks at the evidence for alternative conduits as the second choice after the left internal mammary artery for coronary bypass grafting.
M Dweck (Edinburgh, UK) presents a case of isoated proximal LAD disease. G Laufer (Vienna, Austria) argues in favour of surgery, while C Hamm (Bad Nauheim, Germany) puts forward the case for PCI. P Kolh (Liege, Belgium) considers how the…
V Zamvar (Edinburgh, UK) describes different techniques for assessing intra-operative graft flow.
P Kolh (Leige, Belgium) assesses the evidence for the importance of completeness of myocardial revascularisation in coronary bypass surgery.
C Hamm (Bad Nauheim, Germany) gives a brief assessment of off pump surgery from a cardiologist’s viewpoint.
D Taggart (Oxford, UK) leads an audience discussion on the merits of off-pump coronary bypass surgery.
N Roberts (London, UK) reviews the evidence for aspirin, clopidogrel, statins and ACE-inhibitors in improving graft patency.
D Taggart (Oxford, UK) gives a quick overview of the evidence for radial artery conduit patency rates.
C Hamm (Bad Nauheim, Germany) explains the use of fractional flow reserve (FFR) in the assessment of coronary stenoses.
This is a panel and audience discussion on the importance of completeness of myocardial revascularisation, with particular emphasis on the use of fractional flow reserve (FFR).
J Pepper (London, UK) presents evidence against the use of off-pump coronary bypass surgery.
M S Uva (Lisbon, Portugal) argues in favour of off-pump coronary bypass surgery, reviewing the evidence from randomised controlled trials and meta-analyses.
J Zacharias (Blackpool, UK) shows a video demonstration of the technique before reviewing the evidence for and against endoscopic vein harvest.
D Taggart (Oxford, UK) reviews the evidence for bilateral internal mammary artery use in coronary bypass surgery.
D Souza (Örebro, Sweden) argues that an open vein harvest technique including peri-adventitial fat is best to optimise long-term patency.
Prof G Laufer (Vienna, Austria) argues in favour of CABG in multivessel disease. P Kolh (Liege, Belgium) considers the case in the context of European guidelines. A discussion follows.
J Pepper (London, UK) considers the causes of vein graft occlusion before looking at possible ways to improve results.
G. Angelini (London, UK) describes surgical techniques to improve vein graft patency rates.
G Di Giammarco (Chieti, Italy) describes his experience in graft flow measurement to improve patency outcomes.
M Ruel (Ottawa, Canada) discusses whether single internal mammary artery grafts can adequately supply the heart.
S Rehman (Oxford, UK) discusses intra-operative imaging techniques in CABG surgery. S Westaby (Oxford, UK) argues that probing is sufficient to assess graft patency. R Haaverstad (Bergen, Norway) is in favour of graft assessment with transit time flow measurement and…
D Taggart (Oxford, UK) argues that CABG remains the best therapy for coronary artery disease in 2015.
R Capoun (Bristol, UK) reports on a multicentre randomised trial of shortening cardioplegic arrest time in combined cardiac surgery.
D Taggart (Oxford, UK) gives his perspective on the 2010 European revascularisation guidelines, based on evidence from the literature. A discussion follows.
P Kolh (Liege, Belgium) describes the development of the 2010 European revascularisation guidelines. He emphasises the importance of the heart team and evidence-based protocols. He explores the indications for the different treatment options in stable disease, updating the guidelines with…
N Roberts (London, UK) gives an update on anti-platelet use in coronary bypass surgery patients.
D Hausenloy (London, UK) gives an update on the ERICCA trial of remote ischaemic preconditioning.
D Taggart (Oxford, UK) reviews the evidence for using the radial artery as the first choice of second conduit in coronary bypass surgery.
D Hildick-Smith (Brighton, UK) discusses the FREEDOM trial and other diabetic data in revascularisation, from a cardiologist’s perspective.
P Kolh (Leige, Belgium) promotes the value of the heart team and questions whom should be involved. He considers patient information, medical ethics, time and risk stratification.
P Kolh (Liege, Belgium) considers whether the SYNTAX trial has changed coronary artery disease practice in Europe. He reviews the results, examines the guidelines and emphasises the importance of risk models.
D Hildick-Smith (Brighton, UK) gives an overview of the use of anti-platelet agents in patients underging PCI with stenting.
D Taggart (Oxford, UK) emphasises the need for a heart team to ensure that patients receive the most appropriate guideline-driven interventions.
M Bhabra (Wolverhampton, UK) describes the local structure of his heart team.
N Howell (Birmingham, UK) looks at the timing of stroke after coronary surgery.
B Bridgewater (Manchester, UK) explains the analysis of the UK database data and demonstrates visualisation of the data via the Blue Book Online. A comparison of single versus bilateral mammary usage in coronary revascularisation is then made.
N Khan (Wolverhampton, UK) gives an overview of current antiplatelet agents, their limitations, and looks at strategies to overcome these limitations.
E Verrier (Washington, USA) discusses the revascularisation heart team from a USA perspective.
H Luckraz (Wolverhampton, UK) assesses whether decisions made by the heart team are enacted.
M Norell (Wolverhampton, UK) talks about the role of the revascularisation multidisclipinary heart team from a cardiology viewpoint.
D Taggart (Oxford, UK) presents the 5 year results of the SYNTAX trial, in the context of other evidence in coronary revascularisation.
C McDonald (AstraZeneca) describes the PLATO trial of ticagrelor vs clopidogrel in acute coronary syndrome. The CABG sub-group results are presented.
D Taggart (Oxford, UK) describes the VEST trial of external venous support for coronary bypass grafts.
J Sabik (Cleveland, USA), as part of a debate, argues that off-pump CABG should be abandoned as our default procedure. He reviews results from the major trials as well as metaanalyses to support his view.
J Sabik (Cleveland, USA) considers the evidence for bilateral internal mammary artery usage in coronary bypass surgery. He uses data from the large Cleveland clinic registry to explore the importance of time, coronary vessel anastomosed, conduit used and patient factors…
A de Souza (London, UK) describes his technique for endoscopic internal mammary artery harvest.
JF Sabik (Cleveland, USA) considers whether the SYNTAX trial has changed practice in the USA and, if not, why not? He reviews the trial design and results before looking at registry data to inform about current patterns of coronary artery…
R Stanbridge (London, UK) describes the evolution of minimally invasive coronary surgery from his initial experience in 1995, and considers the results of the procedure.
T Sundt (Boston, USA) gives a brief overview of the evidence for various drugs which could be used to improve vein graft patency.
C Palin (Oxford, UK), a cardiac anaesthetist, explains his view on how practice has become so polarised. This is followed by a panel and audience debate.
G Angelini (Bristol, UK) explains the evolution and current status of hybrid coronary revascularisation.
R Hasan (Manchester, UK) gives an overview of the alternative conduits for bypass grafting. A de Souza (London, UK) reviews to evidence for these conduits.
D Taggart (Oxford, UK) argues in favour of using bilateral internal mammary arteries for surgical revascularisation.
E Akowuah (Middlesbrough, UK) shares his experience of setting up a minimally-invasive coronary surgery programme.
J Ender (Leipzig, Germany) shows cases of circumflex artery injury during mitral valve repair and explains the anatomy to demonstrate how easily this can happen.
D Taggart (Oxford, UK) undertakes a detailed exploration of the evidence for and against off-pump CABG.
T Sundt (Boston, USA) gives a North American view of radial artery use as a bypass conduit.
B Bridgewater (Manchester, UK) presents provisional analysis of off-pump vs on-pump CABG from the SCTS database.
B Fabri (Liverpool, UK) explores the role of the radial artery as a conduit for bypass grafting.
A Wechsler (Philadelphia, USA) explores some of the reasons for polarisation of surgical opinion, including intuition and the retention of biases.
D Glineur (Brussels, Belgium) discusses the off-pump CABG trials and argues for the use of bilateral internal mammary arteries as a composite Y-graft.
D Taggart (Oxford, UK) presents pre-syntax evidence for CABG vs PCI, before analyzing the results of the SYNTAX trial at four years.
G Angelini (Bristol, UK) talks about surgical attitudes to evidence-based medicine, professional competition and lack of innovation.
N Howell (Birmingham, UK) explores whether RIMA-LAD revascularisation is equivalent to LIMA-LAD.
A Wechsler (Philadelphia, USA) reviews the surgical treatment for ischaemic heart failure (STITCH) trial. Problems with trial design, recruitment and results interpretation are highlighted.